Concepedia

Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34+ progenitor-derived dendritic cells

Joseph W. Fay, Karolina Palucka, Sophie Paczesny, Madhav V. Dhodapkar, Dennis A. Johnston, Susan Burkeholder, Hideki Ueno, Jacques Banchereau

Cancer Immunology Immunotherapy · 2005 · 121 citations · 37 references

DOIFull text

Open access

Concepts

References

37

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 38.7K citations

, , +21

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +17

Cancer: Principles and Practice of Oncology.

Annals of Internal Medicine · 1991 · 8.5K citations

, , +14

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Federica Sallusto, Antonio Lanzavecchia · The Journal of Experimental Medicine · 1994 · 5.1K citations · Full text

, , +19

Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

Frank O. Nestlé, Selma Alijagic, Michel Gilliet et al. · Nature Medicine · 1998 · 2.9K citations

, , +7